nodes	percent_of_prediction	percent_of_DWPC	metapath
Dobutamine—COMT—breast cancer	0.689	1	CbGaD
Dobutamine—Skin necrosis—Melphalan—breast cancer	0.00495	0.0315	CcSEcCtD
Dobutamine—Skin necrosis—Vinorelbine—breast cancer	0.00432	0.0275	CcSEcCtD
Dobutamine—CA5A—female reproductive system—breast cancer	0.00332	0.0763	CbGeAlD
Dobutamine—Phlebitis—Carboplatin—breast cancer	0.00325	0.0207	CcSEcCtD
Dobutamine—CA5B—mammary gland—breast cancer	0.00312	0.0715	CbGeAlD
Dobutamine—Skin necrosis—Paclitaxel—breast cancer	0.00291	0.0185	CcSEcCtD
Dobutamine—CA5A—endocrine gland—breast cancer	0.00281	0.0645	CbGeAlD
Dobutamine—Skin exfoliation—Ixabepilone—breast cancer	0.00262	0.0167	CcSEcCtD
Dobutamine—Masoprocol—IGF1R—breast cancer	0.00262	0.488	CrCbGaD
Dobutamine—COMT—nipple—breast cancer	0.00237	0.0544	CbGeAlD
Dobutamine—Phlebitis—Letrozole—breast cancer	0.00217	0.0139	CcSEcCtD
Dobutamine—Phlebitis—Idarubicin—breast cancer	0.00206	0.0131	CcSEcCtD
Dobutamine—Angina pectoris—Toremifene—breast cancer	0.00202	0.0128	CcSEcCtD
Dobutamine—Hypokalaemia—Ixabepilone—breast cancer	0.00181	0.0115	CcSEcCtD
Dobutamine—Skin necrosis—Methotrexate—breast cancer	0.00178	0.0113	CcSEcCtD
Dobutamine—Angina pectoris—Exemestane—breast cancer	0.00177	0.0113	CcSEcCtD
Dobutamine—Skin exfoliation—Tamoxifen—breast cancer	0.00169	0.0107	CcSEcCtD
Dobutamine—Angina pectoris—Ixabepilone—breast cancer	0.00167	0.0107	CcSEcCtD
Dobutamine—Skin necrosis—Epirubicin—breast cancer	0.00166	0.0106	CcSEcCtD
Dobutamine—Skin exfoliation—Melphalan—breast cancer	0.00165	0.0105	CcSEcCtD
Dobutamine—Angina pectoris—Letrozole—breast cancer	0.00158	0.01	CcSEcCtD
Dobutamine—Angina pectoris—Anastrozole—breast cancer	0.00158	0.01	CcSEcCtD
Dobutamine—Skin necrosis—Doxorubicin—breast cancer	0.00154	0.0098	CcSEcCtD
Dobutamine—Phlebitis—Vinblastine—breast cancer	0.00153	0.00976	CcSEcCtD
Dobutamine—COMT—skin of body—breast cancer	0.00152	0.0349	CbGeAlD
Dobutamine—CA2—nipple—breast cancer	0.00147	0.0338	CbGeAlD
Dobutamine—Skin exfoliation—Vinorelbine—breast cancer	0.00144	0.00919	CcSEcCtD
Dobutamine—COMT—endometrium—breast cancer	0.00143	0.0329	CbGeAlD
Dobutamine—Palpitations—Lapatinib—breast cancer	0.0014	0.00895	CcSEcCtD
Dobutamine—CA5B—adipose tissue—breast cancer	0.0014	0.0322	CbGeAlD
Dobutamine—Skin exfoliation—Thiotepa—breast cancer	0.00138	0.00878	CcSEcCtD
Dobutamine—COMT—uterus—breast cancer	0.00132	0.0303	CbGeAlD
Dobutamine—COMT—pituitary gland—breast cancer	0.0013	0.0297	CbGeAlD
Dobutamine—COMT—adipose tissue—breast cancer	0.00129	0.0296	CbGeAlD
Dobutamine—CA5B—female reproductive system—breast cancer	0.00129	0.0296	CbGeAlD
Dobutamine—Phlebitis—Vinorelbine—breast cancer	0.00127	0.00811	CcSEcCtD
Dobutamine—CA5B—adrenal gland—breast cancer	0.00126	0.0288	CbGeAlD
Dobutamine—Chest pain—Fulvestrant—breast cancer	0.00124	0.00793	CcSEcCtD
Dobutamine—Chest pain—Toremifene—breast cancer	0.00123	0.00782	CcSEcCtD
Dobutamine—CA2—embryo—breast cancer	0.00122	0.0279	CbGeAlD
Dobutamine—COMT—female reproductive system—breast cancer	0.00119	0.0272	CbGeAlD
Dobutamine—Skin exfoliation—Gemcitabine—breast cancer	0.00116	0.00738	CcSEcCtD
Dobutamine—COMT—adrenal gland—breast cancer	0.00116	0.0266	CbGeAlD
Dobutamine—Dyspnoea—Lapatinib—breast cancer	0.00116	0.00737	CcSEcCtD
Dobutamine—Thrombocytopenia—Toremifene—breast cancer	0.00115	0.00734	CcSEcCtD
Dobutamine—Headache—Fluoxymesterone—breast cancer	0.00114	0.00729	CcSEcCtD
Dobutamine—Ventricular extrasystoles—Paclitaxel—breast cancer	0.00112	0.00717	CcSEcCtD
Dobutamine—COMT—bone marrow—breast cancer	0.00112	0.0257	CbGeAlD
Dobutamine—Angina pectoris—Vinblastine—breast cancer	0.00111	0.00708	CcSEcCtD
Dobutamine—ADRB1—adipose tissue—breast cancer	0.00109	0.0251	CbGeAlD
Dobutamine—CA5B—endocrine gland—breast cancer	0.00109	0.025	CbGeAlD
Dobutamine—Nausea—Fluoxymesterone—breast cancer	0.00109	0.00691	CcSEcCtD
Dobutamine—Chest pain—Exemestane—breast cancer	0.00108	0.00689	CcSEcCtD
Dobutamine—COMT—female gonad—breast cancer	0.00108	0.0248	CbGeAlD
Dobutamine—Angina pectoris—Tamoxifen—breast cancer	0.00108	0.00688	CcSEcCtD
Dobutamine—Dyspnoea—Fulvestrant—breast cancer	0.00106	0.00678	CcSEcCtD
Dobutamine—Phlebitis—Mitoxantrone—breast cancer	0.00105	0.00669	CcSEcCtD
Dobutamine—Dyspnoea—Toremifene—breast cancer	0.00105	0.00669	CcSEcCtD
Dobutamine—Angina pectoris—Goserelin—breast cancer	0.00103	0.00657	CcSEcCtD
Dobutamine—Chest pain—Ixabepilone—breast cancer	0.00102	0.0065	CcSEcCtD
Dobutamine—Thrombocytopenia—Exemestane—breast cancer	0.00101	0.00646	CcSEcCtD
Dobutamine—ADRB1—female reproductive system—breast cancer	0.00101	0.0231	CbGeAlD
Dobutamine—COMT—endocrine gland—breast cancer	0.001	0.023	CbGeAlD
Dobutamine—Palpitations—Letrozole—breast cancer	0.000997	0.00635	CcSEcCtD
Dobutamine—CA2—epithelium—breast cancer	0.000993	0.0228	CbGeAlD
Dobutamine—Skin exfoliation—Paclitaxel—breast cancer	0.00097	0.00618	CcSEcCtD
Dobutamine—Chest pain—Anastrozole—breast cancer	0.00096	0.00612	CcSEcCtD
Dobutamine—Chest pain—Letrozole—breast cancer	0.00096	0.00612	CcSEcCtD
Dobutamine—Thrombocytopenia—Ixabepilone—breast cancer	0.000957	0.0061	CcSEcCtD
Dobutamine—CA2—skin of body—breast cancer	0.000944	0.0217	CbGeAlD
Dobutamine—Dyspnoea—Exemestane—breast cancer	0.000924	0.00589	CcSEcCtD
Dobutamine—Angina pectoris—Vinorelbine—breast cancer	0.000923	0.00588	CcSEcCtD
Dobutamine—Ventricular extrasystoles—Capecitabine—breast cancer	0.000923	0.00588	CcSEcCtD
Dobutamine—Pruritus—Lapatinib—breast cancer	0.000918	0.00585	CcSEcCtD
Dobutamine—Hypotension—Ixabepilone—breast cancer	0.000913	0.00582	CcSEcCtD
Dobutamine—Chest pain—Raloxifene—breast cancer	0.000911	0.00581	CcSEcCtD
Dobutamine—Chest pain—Idarubicin—breast cancer	0.000911	0.00581	CcSEcCtD
Dobutamine—Tachycardia—Letrozole—breast cancer	0.000898	0.00572	CcSEcCtD
Dobutamine—Dyspnoea—Ixabepilone—breast cancer	0.000872	0.00555	CcSEcCtD
Dobutamine—Phlebitis—Paclitaxel—breast cancer	0.000856	0.00545	CcSEcCtD
Dobutamine—Thrombocytopenia—Idarubicin—breast cancer	0.000855	0.00545	CcSEcCtD
Dobutamine—Thrombocytopenia—Raloxifene—breast cancer	0.000855	0.00545	CcSEcCtD
Dobutamine—ADRB1—endocrine gland—breast cancer	0.000851	0.0195	CbGeAlD
Dobutamine—Pruritus—Fulvestrant—breast cancer	0.000844	0.00538	CcSEcCtD
Dobutamine—Pruritus—Toremifene—breast cancer	0.000833	0.00531	CcSEcCtD
Dobutamine—Masoprocol—CYP19A1—breast cancer	0.000828	0.154	CrCbGaD
Dobutamine—Hypokalaemia—Irinotecan—breast cancer	0.000823	0.00524	CcSEcCtD
Dobutamine—Hypokalaemia—Mitoxantrone—breast cancer	0.000823	0.00524	CcSEcCtD
Dobutamine—Skin exfoliation—Docetaxel—breast cancer	0.000822	0.00524	CcSEcCtD
Dobutamine—Dyspnoea—Anastrozole—breast cancer	0.000821	0.00523	CcSEcCtD
Dobutamine—Dyspnoea—Letrozole—breast cancer	0.000821	0.00523	CcSEcCtD
Dobutamine—Headache—Lapatinib—breast cancer	0.000813	0.00518	CcSEcCtD
Dobutamine—CA2—pituitary gland—breast cancer	0.000806	0.0185	CbGeAlD
Dobutamine—CA2—adipose tissue—breast cancer	0.000802	0.0184	CbGeAlD
Dobutamine—Hypokalaemia—Gemcitabine—breast cancer	0.000802	0.00511	CcSEcCtD
Dobutamine—Skin exfoliation—Capecitabine—breast cancer	0.000796	0.00507	CcSEcCtD
Dobutamine—Nausea—Lapatinib—breast cancer	0.00077	0.00491	CcSEcCtD
Dobutamine—Angina pectoris—Irinotecan—breast cancer	0.000761	0.00485	CcSEcCtD
Dobutamine—CA5B—lymph node—breast cancer	0.000754	0.0173	CbGeAlD
Dobutamine—Headache—Fulvestrant—breast cancer	0.000747	0.00476	CcSEcCtD
Dobutamine—CA2—female reproductive system—breast cancer	0.000738	0.0169	CbGeAlD
Dobutamine—Headache—Toremifene—breast cancer	0.000738	0.0047	CcSEcCtD
Dobutamine—Pruritus—Exemestane—breast cancer	0.000733	0.00467	CcSEcCtD
Dobutamine—Angina pectoris—Fluorouracil—breast cancer	0.000729	0.00465	CcSEcCtD
Dobutamine—Phlebitis—Docetaxel—breast cancer	0.000726	0.00462	CcSEcCtD
Dobutamine—CA2—adrenal gland—breast cancer	0.00072	0.0165	CbGeAlD
Dobutamine—Nausea—Fulvestrant—breast cancer	0.000708	0.00451	CcSEcCtD
Dobutamine—Phlebitis—Capecitabine—breast cancer	0.000702	0.00448	CcSEcCtD
Dobutamine—Nausea—Toremifene—breast cancer	0.000699	0.00446	CcSEcCtD
Dobutamine—CA2—bone marrow—breast cancer	0.000696	0.016	CbGeAlD
Dobutamine—COMT—lymph node—breast cancer	0.000694	0.0159	CbGeAlD
Dobutamine—Thrombocytopenia—Chlorambucil—breast cancer	0.000693	0.00441	CcSEcCtD
Dobutamine—Pruritus—Ixabepilone—breast cancer	0.000692	0.00441	CcSEcCtD
Dobutamine—Hypokalaemia—Paclitaxel—breast cancer	0.000671	0.00428	CcSEcCtD
Dobutamine—CA2—female gonad—breast cancer	0.000671	0.0154	CbGeAlD
Dobutamine—Chest pain—Tamoxifen—breast cancer	0.000657	0.00419	CcSEcCtD
Dobutamine—Palpitations—Goserelin—breast cancer	0.000652	0.00415	CcSEcCtD
Dobutamine—Pruritus—Letrozole—breast cancer	0.000651	0.00415	CcSEcCtD
Dobutamine—Pruritus—Anastrozole—breast cancer	0.000651	0.00415	CcSEcCtD
Dobutamine—Headache—Exemestane—breast cancer	0.000649	0.00414	CcSEcCtD
Dobutamine—Chest pain—Melphalan—breast cancer	0.000643	0.0041	CcSEcCtD
Dobutamine—Ventricular extrasystoles—Epirubicin—breast cancer	0.000643	0.0041	CcSEcCtD
Dobutamine—Thrombocytopenia—Vinblastine—breast cancer	0.000635	0.00405	CcSEcCtD
Dobutamine—Chest pain—Goserelin—breast cancer	0.000628	0.004	CcSEcCtD
Dobutamine—CA2—endocrine gland—breast cancer	0.000624	0.0143	CbGeAlD
Dobutamine—Thrombocytopenia—Tamoxifen—breast cancer	0.000617	0.00393	CcSEcCtD
Dobutamine—Nausea—Exemestane—breast cancer	0.000615	0.00392	CcSEcCtD
Dobutamine—Headache—Ixabepilone—breast cancer	0.000612	0.0039	CcSEcCtD
Dobutamine—Thrombocytopenia—Melphalan—breast cancer	0.000604	0.00385	CcSEcCtD
Dobutamine—Tachycardia—Melphalan—breast cancer	0.000602	0.00384	CcSEcCtD
Dobutamine—Ventricular extrasystoles—Doxorubicin—breast cancer	0.000595	0.00379	CcSEcCtD
Dobutamine—Skin exfoliation—Methotrexate—breast cancer	0.000593	0.00378	CcSEcCtD
Dobutamine—Thrombocytopenia—Goserelin—breast cancer	0.000589	0.00375	CcSEcCtD
Dobutamine—Tachycardia—Goserelin—breast cancer	0.000587	0.00374	CcSEcCtD
Dobutamine—Palpitations—Vinorelbine—breast cancer	0.000584	0.00372	CcSEcCtD
Dobutamine—Nausea—Ixabepilone—breast cancer	0.000581	0.0037	CcSEcCtD
Dobutamine—Headache—Letrozole—breast cancer	0.000577	0.00367	CcSEcCtD
Dobutamine—Headache—Anastrozole—breast cancer	0.000577	0.00367	CcSEcCtD
Dobutamine—Hypotension—Melphalan—breast cancer	0.000576	0.00367	CcSEcCtD
Dobutamine—Dopamine—COMT—breast cancer	0.000571	0.107	CrCbGaD
Dobutamine—Hypotension—Goserelin—breast cancer	0.000562	0.00358	CcSEcCtD
Dobutamine—Chest pain—Vinorelbine—breast cancer	0.000562	0.00358	CcSEcCtD
Dobutamine—Dyspnoea—Tamoxifen—breast cancer	0.000562	0.00358	CcSEcCtD
Dobutamine—Skin exfoliation—Epirubicin—breast cancer	0.000555	0.00353	CcSEcCtD
Dobutamine—Hypokalaemia—Capecitabine—breast cancer	0.000551	0.00351	CcSEcCtD
Dobutamine—Dyspnoea—Melphalan—breast cancer	0.00055	0.0035	CcSEcCtD
Dobutamine—Headache—Raloxifene—breast cancer	0.000547	0.00349	CcSEcCtD
Dobutamine—Headache—Idarubicin—breast cancer	0.000547	0.00349	CcSEcCtD
Dobutamine—Nausea—Anastrozole—breast cancer	0.000547	0.00348	CcSEcCtD
Dobutamine—Nausea—Letrozole—breast cancer	0.000547	0.00348	CcSEcCtD
Dobutamine—Dyspnoea—Goserelin—breast cancer	0.000536	0.00342	CcSEcCtD
Dobutamine—Thrombocytopenia—Vinorelbine—breast cancer	0.000528	0.00336	CcSEcCtD
Dobutamine—Angina pectoris—Docetaxel—breast cancer	0.000526	0.00335	CcSEcCtD
Dobutamine—Tachycardia—Vinorelbine—breast cancer	0.000526	0.00335	CcSEcCtD
Dobutamine—Nausea—Idarubicin—breast cancer	0.000519	0.00331	CcSEcCtD
Dobutamine—Nausea—Raloxifene—breast cancer	0.000519	0.00331	CcSEcCtD
Dobutamine—Skin exfoliation—Doxorubicin—breast cancer	0.000513	0.00327	CcSEcCtD
Dobutamine—Angina pectoris—Capecitabine—breast cancer	0.00051	0.00325	CcSEcCtD
Dobutamine—Thrombocytopenia—Thiotepa—breast cancer	0.000504	0.00321	CcSEcCtD
Dobutamine—Hypotension—Vinorelbine—breast cancer	0.000504	0.00321	CcSEcCtD
Dobutamine—Tachycardia—Thiotepa—breast cancer	0.000502	0.0032	CcSEcCtD
Dobutamine—Pruritus—Chlorambucil—breast cancer	0.000501	0.00319	CcSEcCtD
Dobutamine—Phlebitis—Epirubicin—breast cancer	0.000489	0.00312	CcSEcCtD
Dobutamine—Dyspnoea—Vinorelbine—breast cancer	0.00048	0.00306	CcSEcCtD
Dobutamine—Chest pain—Mitoxantrone—breast cancer	0.000464	0.00295	CcSEcCtD
Dobutamine—Phlebitis—Doxorubicin—breast cancer	0.000453	0.00289	CcSEcCtD
Dobutamine—Chest pain—Gemcitabine—breast cancer	0.000452	0.00288	CcSEcCtD
Dobutamine—Pruritus—Tamoxifen—breast cancer	0.000446	0.00284	CcSEcCtD
Dobutamine—Chest pain—Fluorouracil—breast cancer	0.000444	0.00283	CcSEcCtD
Dobutamine—Pruritus—Melphalan—breast cancer	0.000436	0.00278	CcSEcCtD
Dobutamine—Thrombocytopenia—Mitoxantrone—breast cancer	0.000435	0.00277	CcSEcCtD
Dobutamine—Thrombocytopenia—Irinotecan—breast cancer	0.000435	0.00277	CcSEcCtD
Dobutamine—Tachycardia—Mitoxantrone—breast cancer	0.000434	0.00276	CcSEcCtD
Dobutamine—CA2—lymph node—breast cancer	0.000431	0.0099	CbGeAlD
Dobutamine—Pruritus—Goserelin—breast cancer	0.000426	0.00271	CcSEcCtD
Dobutamine—Thrombocytopenia—Gemcitabine—breast cancer	0.000424	0.0027	CcSEcCtD
Dobutamine—Formoterol—CYP2D6—breast cancer	0.000421	0.0786	CrCbGaD
Dobutamine—Arformoterol—CYP2D6—breast cancer	0.000421	0.0786	CrCbGaD
Dobutamine—Nausea—Chlorambucil—breast cancer	0.00042	0.00268	CcSEcCtD
Dobutamine—Thrombocytopenia—Fluorouracil—breast cancer	0.000417	0.00266	CcSEcCtD
Dobutamine—Tachycardia—Fluorouracil—breast cancer	0.000415	0.00265	CcSEcCtD
Dobutamine—Hypotension—Irinotecan—breast cancer	0.000415	0.00265	CcSEcCtD
Dobutamine—Hypotension—Mitoxantrone—breast cancer	0.000415	0.00265	CcSEcCtD
Dobutamine—Headache—Vinblastine—breast cancer	0.000406	0.00259	CcSEcCtD
Dobutamine—Hypotension—Gemcitabine—breast cancer	0.000405	0.00258	CcSEcCtD
Dobutamine—Hypotension—Fluorouracil—breast cancer	0.000398	0.00253	CcSEcCtD
Dobutamine—Dyspnoea—Irinotecan—breast cancer	0.000396	0.00252	CcSEcCtD
Dobutamine—Dyspnoea—Mitoxantrone—breast cancer	0.000396	0.00252	CcSEcCtD
Dobutamine—Headache—Tamoxifen—breast cancer	0.000395	0.00251	CcSEcCtD
Dobutamine—Palpitations—Paclitaxel—breast cancer	0.000392	0.0025	CcSEcCtD
Dobutamine—Dyspnoea—Gemcitabine—breast cancer	0.000386	0.00246	CcSEcCtD
Dobutamine—Nausea—Vinblastine—breast cancer	0.000385	0.00245	CcSEcCtD
Dobutamine—Hypokalaemia—Epirubicin—breast cancer	0.000384	0.00244	CcSEcCtD
Dobutamine—Pruritus—Vinorelbine—breast cancer	0.000381	0.00243	CcSEcCtD
Dobutamine—Dyspnoea—Fluorouracil—breast cancer	0.000379	0.00242	CcSEcCtD
Dobutamine—Chest pain—Paclitaxel—breast cancer	0.000378	0.00241	CcSEcCtD
Dobutamine—Headache—Goserelin—breast cancer	0.000377	0.0024	CcSEcCtD
Dobutamine—Nausea—Tamoxifen—breast cancer	0.000374	0.00238	CcSEcCtD
Dobutamine—Nausea—Melphalan—breast cancer	0.000366	0.00233	CcSEcCtD
Dobutamine—Pruritus—Thiotepa—breast cancer	0.000364	0.00232	CcSEcCtD
Dobutamine—Nausea—Goserelin—breast cancer	0.000357	0.00228	CcSEcCtD
Dobutamine—Hypokalaemia—Doxorubicin—breast cancer	0.000355	0.00226	CcSEcCtD
Dobutamine—Angina pectoris—Epirubicin—breast cancer	0.000355	0.00226	CcSEcCtD
Dobutamine—Thrombocytopenia—Paclitaxel—breast cancer	0.000355	0.00226	CcSEcCtD
Dobutamine—Tachycardia—Paclitaxel—breast cancer	0.000354	0.00225	CcSEcCtD
Dobutamine—Hypotension—Paclitaxel—breast cancer	0.000339	0.00216	CcSEcCtD
Dobutamine—Headache—Vinorelbine—breast cancer	0.000338	0.00215	CcSEcCtD
Dobutamine—Palpitations—Docetaxel—breast cancer	0.000333	0.00212	CcSEcCtD
Dobutamine—Angina pectoris—Doxorubicin—breast cancer	0.000328	0.00209	CcSEcCtD
Dobutamine—Dyspnoea—Paclitaxel—breast cancer	0.000323	0.00206	CcSEcCtD
Dobutamine—Headache—Thiotepa—breast cancer	0.000322	0.00205	CcSEcCtD
Dobutamine—Palpitations—Capecitabine—breast cancer	0.000322	0.00205	CcSEcCtD
Dobutamine—Chest pain—Docetaxel—breast cancer	0.00032	0.00204	CcSEcCtD
Dobutamine—Nausea—Vinorelbine—breast cancer	0.00032	0.00204	CcSEcCtD
Dobutamine—Chest pain—Capecitabine—breast cancer	0.00031	0.00198	CcSEcCtD
Dobutamine—Labetalol—CYP2D6—breast cancer	0.000308	0.0575	CrCbGaD
Dobutamine—Pruritus—Gemcitabine—breast cancer	0.000306	0.00195	CcSEcCtD
Dobutamine—Nausea—Thiotepa—breast cancer	0.000306	0.00195	CcSEcCtD
Dobutamine—Pruritus—Fluorouracil—breast cancer	0.000301	0.00192	CcSEcCtD
Dobutamine—Thrombocytopenia—Docetaxel—breast cancer	0.000301	0.00192	CcSEcCtD
Dobutamine—Tachycardia—Docetaxel—breast cancer	0.0003	0.00191	CcSEcCtD
Dobutamine—Thrombocytopenia—Capecitabine—breast cancer	0.000291	0.00186	CcSEcCtD
Dobutamine—Tachycardia—Capecitabine—breast cancer	0.00029	0.00185	CcSEcCtD
Dobutamine—Hypotension—Docetaxel—breast cancer	0.000287	0.00183	CcSEcCtD
Dobutamine—Headache—Irinotecan—breast cancer	0.000278	0.00177	CcSEcCtD
Dobutamine—Headache—Mitoxantrone—breast cancer	0.000278	0.00177	CcSEcCtD
Dobutamine—Hypotension—Capecitabine—breast cancer	0.000278	0.00177	CcSEcCtD
Dobutamine—Dyspnoea—Docetaxel—breast cancer	0.000274	0.00175	CcSEcCtD
Dobutamine—Headache—Gemcitabine—breast cancer	0.000271	0.00173	CcSEcCtD
Dobutamine—Headache—Fluorouracil—breast cancer	0.000267	0.0017	CcSEcCtD
Dobutamine—Dyspnoea—Capecitabine—breast cancer	0.000265	0.00169	CcSEcCtD
Dobutamine—Nausea—Mitoxantrone—breast cancer	0.000264	0.00168	CcSEcCtD
Dobutamine—Nausea—Irinotecan—breast cancer	0.000264	0.00168	CcSEcCtD
Dobutamine—Nausea—Gemcitabine—breast cancer	0.000257	0.00164	CcSEcCtD
Dobutamine—Pruritus—Paclitaxel—breast cancer	0.000256	0.00163	CcSEcCtD
Dobutamine—Nausea—Fluorouracil—breast cancer	0.000253	0.00161	CcSEcCtD
Dobutamine—Chest pain—Methotrexate—breast cancer	0.000231	0.00147	CcSEcCtD
Dobutamine—Headache—Paclitaxel—breast cancer	0.000227	0.00145	CcSEcCtD
Dobutamine—Palpitations—Epirubicin—breast cancer	0.000224	0.00143	CcSEcCtD
Dobutamine—Pruritus—Docetaxel—breast cancer	0.000217	0.00138	CcSEcCtD
Dobutamine—Thrombocytopenia—Methotrexate—breast cancer	0.000217	0.00138	CcSEcCtD
Dobutamine—Chest pain—Epirubicin—breast cancer	0.000216	0.00138	CcSEcCtD
Dobutamine—Nausea—Paclitaxel—breast cancer	0.000215	0.00137	CcSEcCtD
Dobutamine—Pruritus—Capecitabine—breast cancer	0.00021	0.00134	CcSEcCtD
Dobutamine—Palpitations—Doxorubicin—breast cancer	0.000208	0.00132	CcSEcCtD
Dobutamine—Hypotension—Methotrexate—breast cancer	0.000207	0.00132	CcSEcCtD
Dobutamine—Thrombocytopenia—Epirubicin—breast cancer	0.000203	0.00129	CcSEcCtD
Dobutamine—Tachycardia—Epirubicin—breast cancer	0.000202	0.00129	CcSEcCtD
Dobutamine—Chest pain—Doxorubicin—breast cancer	0.0002	0.00127	CcSEcCtD
Dobutamine—Dyspnoea—Methotrexate—breast cancer	0.000197	0.00126	CcSEcCtD
Dobutamine—Dopamine—CYP2D6—breast cancer	0.000195	0.0364	CrCbGaD
Dobutamine—Hypotension—Epirubicin—breast cancer	0.000194	0.00123	CcSEcCtD
Dobutamine—Headache—Docetaxel—breast cancer	0.000192	0.00123	CcSEcCtD
Dobutamine—Thrombocytopenia—Doxorubicin—breast cancer	0.000188	0.0012	CcSEcCtD
Dobutamine—Tachycardia—Doxorubicin—breast cancer	0.000187	0.00119	CcSEcCtD
Dobutamine—Headache—Capecitabine—breast cancer	0.000186	0.00119	CcSEcCtD
Dobutamine—Dyspnoea—Epirubicin—breast cancer	0.000185	0.00118	CcSEcCtD
Dobutamine—Nausea—Docetaxel—breast cancer	0.000182	0.00116	CcSEcCtD
Dobutamine—Hypotension—Doxorubicin—breast cancer	0.000179	0.00114	CcSEcCtD
Dobutamine—Nausea—Capecitabine—breast cancer	0.000177	0.00113	CcSEcCtD
Dobutamine—Dyspnoea—Doxorubicin—breast cancer	0.000171	0.00109	CcSEcCtD
Dobutamine—Pruritus—Methotrexate—breast cancer	0.000157	0.000998	CcSEcCtD
Dobutamine—Pruritus—Epirubicin—breast cancer	0.000147	0.000934	CcSEcCtD
Dobutamine—Headache—Methotrexate—breast cancer	0.000139	0.000884	CcSEcCtD
Dobutamine—Pruritus—Doxorubicin—breast cancer	0.000136	0.000864	CcSEcCtD
Dobutamine—Nausea—Methotrexate—breast cancer	0.000132	0.000838	CcSEcCtD
Dobutamine—Headache—Epirubicin—breast cancer	0.00013	0.000827	CcSEcCtD
Dobutamine—Nausea—Epirubicin—breast cancer	0.000123	0.000784	CcSEcCtD
Dobutamine—Headache—Doxorubicin—breast cancer	0.00012	0.000765	CcSEcCtD
Dobutamine—Nausea—Doxorubicin—breast cancer	0.000114	0.000726	CcSEcCtD
Dobutamine—CA2—Metabolism—PTGS2—breast cancer	1.79e-05	0.00017	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—CXCL2—breast cancer	1.78e-05	0.000169	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—AGTR2—breast cancer	1.78e-05	0.000169	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—PTHLH—breast cancer	1.76e-05	0.000168	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—BMP2—breast cancer	1.76e-05	0.000168	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—EDNRB—breast cancer	1.74e-05	0.000166	CbGpPWpGaD
Dobutamine—COMT—Metabolism—PIK3CD—breast cancer	1.73e-05	0.000165	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—PGR—breast cancer	1.73e-05	0.000164	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—THBS1—breast cancer	1.72e-05	0.000163	CbGpPWpGaD
Dobutamine—COMT—Metabolism—ALB—breast cancer	1.71e-05	0.000163	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—EDNRB—breast cancer	1.71e-05	0.000162	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—PGR—breast cancer	1.69e-05	0.000161	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—THBS1—breast cancer	1.68e-05	0.00016	CbGpPWpGaD
Dobutamine—CA5A—Metabolism—PIK3CA—breast cancer	1.66e-05	0.000158	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—FLT1—breast cancer	1.64e-05	0.000156	CbGpPWpGaD
Dobutamine—COMT—Metabolism—NOS3—breast cancer	1.64e-05	0.000156	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—SQSTM1—breast cancer	1.63e-05	0.000155	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—FGF3—breast cancer	1.63e-05	0.000155	CbGpPWpGaD
Dobutamine—ADRB1—GPCR downstream signaling—PIK3CG—breast cancer	1.62e-05	0.000155	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—JAG1—breast cancer	1.61e-05	0.000153	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—NOTCH3—breast cancer	1.61e-05	0.000153	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—PARP1—breast cancer	1.61e-05	0.000153	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—FLT1—breast cancer	1.6e-05	0.000153	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—FGF3—breast cancer	1.6e-05	0.000152	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—SQSTM1—breast cancer	1.6e-05	0.000152	CbGpPWpGaD
Dobutamine—ADRB2—GPCR downstream signaling—PIK3CG—breast cancer	1.59e-05	0.000151	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—CALCA—breast cancer	1.59e-05	0.000151	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—JAG1—breast cancer	1.58e-05	0.00015	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—NOTCH3—breast cancer	1.57e-05	0.000149	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—PARP1—breast cancer	1.57e-05	0.000149	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—RPS6—breast cancer	1.57e-05	0.000149	CbGpPWpGaD
Dobutamine—CA2—Metabolism—PTEN—breast cancer	1.56e-05	0.000148	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—FGF4—breast cancer	1.55e-05	0.000148	CbGpPWpGaD
Dobutamine—CA5B—Metabolism—PIK3CA—breast cancer	1.55e-05	0.000148	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—CALCA—breast cancer	1.55e-05	0.000148	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—CXCR4—breast cancer	1.55e-05	0.000147	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—CXCL12—breast cancer	1.55e-05	0.000147	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—RPS6—breast cancer	1.53e-05	0.000146	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—FGF4—breast cancer	1.52e-05	0.000145	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—PAK1—breast cancer	1.52e-05	0.000145	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—CXCR4—breast cancer	1.51e-05	0.000144	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—CXCL12—breast cancer	1.51e-05	0.000144	CbGpPWpGaD
Dobutamine—COMT—Metabolism—PIK3CB—breast cancer	1.51e-05	0.000144	CbGpPWpGaD
Dobutamine—COMT—Metabolism—PTGS2—breast cancer	1.5e-05	0.000142	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—TCF7L2—breast cancer	1.49e-05	0.000142	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—PAK1—breast cancer	1.49e-05	0.000141	CbGpPWpGaD
Dobutamine—ADRB1—GPCR downstream signaling—AKT2—breast cancer	1.49e-05	0.000141	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—PIK3CG—breast cancer	1.48e-05	0.00014	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—TCF7L2—breast cancer	1.46e-05	0.000139	CbGpPWpGaD
Dobutamine—ADRB2—GPCR downstream signaling—AKT2—breast cancer	1.45e-05	0.000138	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—PIK3CG—breast cancer	1.44e-05	0.000137	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—HSP90AA1—breast cancer	1.44e-05	0.000137	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—NOTCH2—breast cancer	1.44e-05	0.000137	CbGpPWpGaD
Dobutamine—ADRB1—GPCR downstream signaling—PIK3CD—breast cancer	1.43e-05	0.000136	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—HSP90AA1—breast cancer	1.41e-05	0.000134	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—NOTCH2—breast cancer	1.41e-05	0.000134	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—PRL—breast cancer	1.4e-05	0.000133	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—AGTR1—breast cancer	1.4e-05	0.000133	CbGpPWpGaD
Dobutamine—ADRB2—GPCR downstream signaling—PIK3CD—breast cancer	1.4e-05	0.000133	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—STK11—breast cancer	1.38e-05	0.000131	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—ADAM10—breast cancer	1.38e-05	0.000131	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—AGTR1—breast cancer	1.37e-05	0.00013	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—PRL—breast cancer	1.37e-05	0.00013	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—PLG—breast cancer	1.36e-05	0.00013	CbGpPWpGaD
Dobutamine—CA5A—Metabolism—AKT1—breast cancer	1.36e-05	0.000129	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—ADAM10—breast cancer	1.35e-05	0.000128	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—STK11—breast cancer	1.35e-05	0.000128	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—AKT2—breast cancer	1.35e-05	0.000128	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—FGF10—breast cancer	1.34e-05	0.000128	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—PLG—breast cancer	1.34e-05	0.000127	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—AKT2—breast cancer	1.32e-05	0.000126	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—FGF10—breast cancer	1.31e-05	0.000125	CbGpPWpGaD
Dobutamine—COMT—Metabolism—PTEN—breast cancer	1.31e-05	0.000124	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—PIK3CD—breast cancer	1.3e-05	0.000123	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—PDGFA—breast cancer	1.3e-05	0.000123	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—TGFBR2—breast cancer	1.28e-05	0.000121	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—PIK3CD—breast cancer	1.27e-05	0.000121	CbGpPWpGaD
Dobutamine—CA5B—Metabolism—AKT1—breast cancer	1.27e-05	0.000121	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—PDGFA—breast cancer	1.27e-05	0.000121	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—ITPR1—breast cancer	1.26e-05	0.00012	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—TGFBR2—breast cancer	1.25e-05	0.000119	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—STAT5A—breast cancer	1.25e-05	0.000119	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—ERBB4—breast cancer	1.25e-05	0.000119	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—MMP3—breast cancer	1.25e-05	0.000119	CbGpPWpGaD
Dobutamine—ADRB1—GPCR downstream signaling—PIK3CB—breast cancer	1.24e-05	0.000118	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—ITPR1—breast cancer	1.23e-05	0.000117	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—ERBB4—breast cancer	1.22e-05	0.000116	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—STAT5A—breast cancer	1.22e-05	0.000116	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—MMP3—breast cancer	1.22e-05	0.000116	CbGpPWpGaD
Dobutamine—ADRB2—GPCR downstream signaling—PIK3CB—breast cancer	1.22e-05	0.000116	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—SMAD4—breast cancer	1.21e-05	0.000115	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—IGF1R—breast cancer	1.2e-05	0.000114	CbGpPWpGaD
Dobutamine—ADRB1—GPCR downstream signaling—CXCL8—breast cancer	1.2e-05	0.000114	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—SMAD4—breast cancer	1.18e-05	0.000112	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—HES1—breast cancer	1.18e-05	0.000112	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—IGF1R—breast cancer	1.18e-05	0.000112	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—PLA2G4A—breast cancer	1.17e-05	0.000112	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—NCOR1—breast cancer	1.17e-05	0.000112	CbGpPWpGaD
Dobutamine—ADRB2—GPCR downstream signaling—CXCL8—breast cancer	1.17e-05	0.000111	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—FGF1—breast cancer	1.16e-05	0.00011	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—CSF2—breast cancer	1.16e-05	0.00011	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—RAF1—breast cancer	1.16e-05	0.00011	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—HES1—breast cancer	1.15e-05	0.00011	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—NRG1—breast cancer	1.15e-05	0.00011	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—NCOR1—breast cancer	1.15e-05	0.000109	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—PLA2G4A—breast cancer	1.15e-05	0.000109	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—H2AFX—breast cancer	1.14e-05	0.000109	CbGpPWpGaD
Dobutamine—ADRB1—GPCR downstream signaling—IL2—breast cancer	1.14e-05	0.000109	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—E2F1—breast cancer	1.14e-05	0.000108	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—CSF2—breast cancer	1.14e-05	0.000108	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—FGF1—breast cancer	1.14e-05	0.000108	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—RAF1—breast cancer	1.13e-05	0.000108	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—PIK3CB—breast cancer	1.13e-05	0.000108	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—NRG1—breast cancer	1.13e-05	0.000107	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—H2AFX—breast cancer	1.12e-05	0.000106	CbGpPWpGaD
Dobutamine—ADRB2—GPCR downstream signaling—IL2—breast cancer	1.12e-05	0.000106	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—E2F1—breast cancer	1.11e-05	0.000106	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—PIK3CB—breast cancer	1.11e-05	0.000105	CbGpPWpGaD
Dobutamine—CA2—Metabolism—PIK3CA—breast cancer	1.1e-05	0.000105	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—SPP1—breast cancer	1.09e-05	0.000104	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—CXCL8—breast cancer	1.09e-05	0.000103	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—ERBB3—breast cancer	1.08e-05	0.000103	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—FGFR2—breast cancer	1.08e-05	0.000102	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—SPP1—breast cancer	1.07e-05	0.000102	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—CXCL8—breast cancer	1.06e-05	0.000101	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—ERBB3—breast cancer	1.06e-05	0.0001	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—FGFR2—breast cancer	1.05e-05	0.0001	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—IL2—breast cancer	1.04e-05	9.87e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—TERT—breast cancer	1.03e-05	9.84e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—IL2—breast cancer	1.02e-05	9.66e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—TERT—breast cancer	1.01e-05	9.62e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—FGFR1—breast cancer	1e-05	9.55e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—HIF1A—breast cancer	9.89e-06	9.41e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—FGFR1—breast cancer	9.82e-06	9.34e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—HIF1A—breast cancer	9.68e-06	9.2e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—LEP—breast cancer	9.66e-06	9.18e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—CAV1—breast cancer	9.57e-06	9.1e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—KDR—breast cancer	9.46e-06	9e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—LEP—breast cancer	9.45e-06	8.98e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—CAV1—breast cancer	9.36e-06	8.9e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—KDR—breast cancer	9.25e-06	8.8e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—ESR1—breast cancer	9.22e-06	8.77e-05	CbGpPWpGaD
Dobutamine—COMT—Metabolism—PIK3CA—breast cancer	9.21e-06	8.76e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—FN1—breast cancer	9.11e-06	8.66e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—ESR1—breast cancer	9.02e-06	8.58e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—NFKBIA—breast cancer	9e-06	8.56e-05	CbGpPWpGaD
Dobutamine—CA2—Metabolism—AKT1—breast cancer	8.98e-06	8.54e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—NOTCH1—breast cancer	8.91e-06	8.48e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—FN1—breast cancer	8.91e-06	8.47e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—NFKBIA—breast cancer	8.8e-06	8.37e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—NOTCH1—breast cancer	8.72e-06	8.29e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—PIK3CG—breast cancer	8.71e-06	8.29e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—APC—breast cancer	8.71e-06	8.29e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—KIT—breast cancer	8.71e-06	8.29e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—EGF—breast cancer	8.61e-06	8.19e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—APC—breast cancer	8.52e-06	8.11e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—PIK3CG—breast cancer	8.52e-06	8.11e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—KIT—breast cancer	8.52e-06	8.11e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—EGF—breast cancer	8.43e-06	8.01e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—MAPK3—breast cancer	8.35e-06	7.94e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—BRAF—breast cancer	8.19e-06	7.79e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—MAPK3—breast cancer	8.16e-06	7.76e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—BRAF—breast cancer	8.01e-06	7.62e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—IGF1—breast cancer	7.98e-06	7.59e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—AKT2—breast cancer	7.97e-06	7.58e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—EGFR—breast cancer	7.94e-06	7.55e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—IGF1—breast cancer	7.81e-06	7.42e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—AKT2—breast cancer	7.8e-06	7.42e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—EGFR—breast cancer	7.77e-06	7.39e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—PIK3CD—breast cancer	7.66e-06	7.29e-05	CbGpPWpGaD
Dobutamine—ADRB1—GPCR downstream signaling—PIK3CA—breast cancer	7.59e-06	7.22e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—SERPINE1—breast cancer	7.58e-06	7.21e-05	CbGpPWpGaD
Dobutamine—COMT—Metabolism—AKT1—breast cancer	7.52e-06	7.15e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—KRAS—breast cancer	7.5e-06	7.13e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—PIK3CD—breast cancer	7.49e-06	7.13e-05	CbGpPWpGaD
Dobutamine—ADRB2—GPCR downstream signaling—PIK3CA—breast cancer	7.42e-06	7.06e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—SERPINE1—breast cancer	7.41e-06	7.05e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—KRAS—breast cancer	7.34e-06	6.98e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—NOS3—breast cancer	7.23e-06	6.88e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—NOS3—breast cancer	7.08e-06	6.73e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—PIK3CA—breast cancer	6.89e-06	6.55e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—MDM2—breast cancer	6.86e-06	6.53e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—RAF1—breast cancer	6.84e-06	6.5e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—RELA—breast cancer	6.81e-06	6.48e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—ERBB2—breast cancer	6.77e-06	6.44e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—PIK3CA—breast cancer	6.74e-06	6.41e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—MDM2—breast cancer	6.71e-06	6.39e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—RAF1—breast cancer	6.69e-06	6.36e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—MTOR—breast cancer	6.68e-06	6.35e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—PIK3CB—breast cancer	6.68e-06	6.35e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—RELA—breast cancer	6.66e-06	6.34e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—ERBB2—breast cancer	6.62e-06	6.3e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—MTOR—breast cancer	6.53e-06	6.21e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—PIK3CB—breast cancer	6.53e-06	6.21e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—CXCL8—breast cancer	6.42e-06	6.1e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—HRAS—breast cancer	6.38e-06	6.06e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—CXCL8—breast cancer	6.28e-06	5.97e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—CDKN1B—breast cancer	6.27e-06	5.96e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—HRAS—breast cancer	6.24e-06	5.93e-05	CbGpPWpGaD
Dobutamine—ADRB1—GPCR downstream signaling—AKT1—breast cancer	6.2e-06	5.9e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—CASP3—breast cancer	6.14e-06	5.84e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—IL2—breast cancer	6.13e-06	5.83e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—CDKN1B—breast cancer	6.13e-06	5.83e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—IL6—breast cancer	6.1e-06	5.8e-05	CbGpPWpGaD
Dobutamine—ADRB2—GPCR downstream signaling—AKT1—breast cancer	6.06e-06	5.77e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—CASP3—breast cancer	6.01e-06	5.71e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—IL2—breast cancer	6e-06	5.71e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—CCND1—breast cancer	5.98e-06	5.69e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—IL6—breast cancer	5.97e-06	5.68e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—JUN—breast cancer	5.97e-06	5.67e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—CTNNB1—breast cancer	5.92e-06	5.63e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—CCND1—breast cancer	5.85e-06	5.56e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—JUN—breast cancer	5.84e-06	5.55e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—MMP9—breast cancer	5.8e-06	5.52e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—CTNNB1—breast cancer	5.79e-06	5.51e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—CDKN1A—breast cancer	5.78e-06	5.5e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—PTEN—breast cancer	5.77e-06	5.49e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—MMP9—breast cancer	5.68e-06	5.4e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—CDKN1A—breast cancer	5.66e-06	5.38e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—MAPK8—breast cancer	5.64e-06	5.37e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—PTEN—breast cancer	5.64e-06	5.37e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—AKT1—breast cancer	5.63e-06	5.35e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—MAPK8—breast cancer	5.52e-06	5.25e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—AKT1—breast cancer	5.51e-06	5.24e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—SRC—breast cancer	5.35e-06	5.09e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—SRC—breast cancer	5.23e-06	4.98e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—VEGFA—breast cancer	5.21e-06	4.96e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—STAT3—breast cancer	5.16e-06	4.91e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—VEGFA—breast cancer	5.1e-06	4.85e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—STAT3—breast cancer	5.05e-06	4.8e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—MAPK3—breast cancer	4.93e-06	4.69e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—MAPK3—breast cancer	4.82e-06	4.59e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—MYC—breast cancer	4.8e-06	4.56e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—TGFB1—breast cancer	4.78e-06	4.55e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—MYC—breast cancer	4.69e-06	4.46e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—EGFR—breast cancer	4.69e-06	4.46e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—TGFB1—breast cancer	4.68e-06	4.45e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—EGFR—breast cancer	4.59e-06	4.36e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—KRAS—breast cancer	4.43e-06	4.21e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—KRAS—breast cancer	4.33e-06	4.12e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—PIK3CA—breast cancer	4.07e-06	3.87e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—PIK3CA—breast cancer	3.98e-06	3.79e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—TP53—breast cancer	3.94e-06	3.75e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—TP53—breast cancer	3.85e-06	3.66e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—HRAS—breast cancer	3.77e-06	3.58e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—HRAS—breast cancer	3.68e-06	3.5e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—IL6—breast cancer	3.6e-06	3.43e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—IL6—breast cancer	3.53e-06	3.35e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—AKT1—breast cancer	3.33e-06	3.16e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—AKT1—breast cancer	3.25e-06	3.09e-05	CbGpPWpGaD
